ARTICLE | Emerging Company Profile
Moderna: Funding the messenger
Moderna developing mRNA technology for faster, cheaper therapeutic proteins
January 28, 2013 8:00 AM UTC
Moderna Therapeutics Inc. expects its messenger RNA Therapeutics platform can reduce the time and expense of producing therapeutic proteins compared with recombinant technologies.
The company delivers modified mRNAs by subcutaneous or intramuscular injection, and the molecules are translated into therapeutic proteinsin vivo...